Sofinnova Investments, Inc. Rigel Pharmaceuticals Inc Transaction History

Sofinnova Investments, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $604,657 - $1.4 Million	-339,695 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.41 - $2.05 $1.56 Million - $2.27 Million	-1,106,623 Reduced 76.51%	339,695 $622,000
Q1 2020 May 13, 2020	BUY	$1.27 - $3.0 $1.84 Million - $4.34 Million	1,446,318 New	1,446,318 $2.26 Million
Q1 2019 May 15, 2019	SELL	$2.0 - $2.65 $6.76 Million - $8.96 Million	-3,382,174 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $252,185 - $407,376	121,243 Added 3.72%	3,382,174 $7.78 Million
Q3 2018 Nov 15, 2018	BUY	$2.6 - $3.59 $2.57 Million - $3.55 Million	988,204 Added 43.48%	3,260,931 $10.5 Million
Q2 2018 Nov 15, 2018	BUY	$2.83 - $4.11 $5.77 Million - $8.38 Million	2,038,620 Added 870.81%	2,272,727 $6.43 Million
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $371,106 - $538,956	131,133 Added 127.35%	234,107 $663,000
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $364,527 - $467,501	102,974 New	102,974 $365,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $3.31B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.